{'fraction_non_alphanumeric': 0.02865761689291101, 'fraction_numerical': 0.0, 'mean_word_length': 5.446601941747573, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Pseudoseizures and Pseudo-Toxicity Syndrome for Secondary Gain

The clinical management of seizure disorders in prisoners often is difficult. This task is more challenging when a toxicity syndrome develops secondary to anti-convulsant therapy for epilepsy. Additionally, prisoners may develop pseudoseizures (PS) or pseudo-toxicity syndrome (PTS) for secondary gain. The co-occurrence of these disorders has not been reported previously in the literature. Since the above issues can be very complex, patients (especially prisoners) with PS and/or PTS appear to be best served by a biopsychosocial multi-disciplinary team approach for both diagnosis and treatment.